Researcher
Jozefien Buyze
Affiliations
- Clinical Trials Unit (Research unit)
Member
From1 Aug 2012 → 18 Jul 2021 - HIV and Tuberculosis (Research unit)
Member
From31 Jul 2012 → 27 Feb 2015 - Clinical Trials Unit (Research unit)
Member
From31 Jul 2012 → 16 Apr 2015
Projects
1 - 3 of 3
- Preventing Resistance in Gonorrhoea StudyFrom1 Oct 2018 → Today
- Novel High-Dose Tuberculosis Retreatment Regimens: How to overcome resistance without creating more?From1 Oct 2018 → Today
- Syndromic approach to neglected infectious diseases (NID) at primary health care level : an international collaboration on integrated diagnosis-treatment platformsFrom1 Nov 2010 → 30 Apr 2016
Publications
1 - 10 of 70
- Gonococcal bacterial load in PrEP users with Mycoplasma genitalium coinfection(2022)
Authors: Christophe Van Dijck, Irith De Baetselier, Vicky Cuylaerts, Jozefien Buyze, Jolein Laumen, Beatrijs Vuylsteke, Christopher Kenyon
Pages: 129-135 - Accuracy of C-reactive protein and procalcitonin for diagnosing bacterial infections among subjects with persistent fever in the tropics(2022)
Authors: Lukas Van Duffel, Cedric P. Yansouni, Jan Jacobs, Marjan Van Esbroeck, Kadrie Ramadan, Jozefien Buyze, Achilleas Tsoumanis, Barbara Barbé, M Boelaert, Kristien Verdonck, et al.
Pages: ofac434 - The population-level effect of screening for M. genitalium on antimicrobial resistance: a quasi-experimental study(2021)
Authors: Christopher Kenyon, Irith De Baetselier, Thibaut Vanbaelen, Jozefien Buyze, Eric Florence
Pages: 629-634 - Development of a risk score to guide targeted hepatitis C testing among human immunodeficiency virus patients in Cambodia(2021)
Authors: Anja De Weggheleire, Jozefien Buyze, Sokkab An, Sopheak Thai, J van Griensven, Sven Francque, Lut Lynen
Pages: 1167-1180 - Finding the right balance between efficacy and tolerability for TB treatment: the search continues(2021)
Authors: A.K.J. Maug, M.A. Hossain, Mourad Gumusboga, Tom Decroo, Wim Mulders, Sofie Braet, Jozefien Buyze, D A Jiménez, Céline Schurmans, Natacha Herssens, et al.
Pages: 84-86 - The impact of physical restriction measures imposed during the two waves of COVID-19 on chlamydia and gonorrhea diagnoses in Belgium: results of an sexually transmitted infection clinic(2021)
Authors: Irith De Baetselier, Ludwig Apers, Tom Platteau, Jozefien Buyze, Eric Florence, Christopher Kenyon, Dorien Van den Bossche
Pages: 998-1003 - Hepatitis C prevalence and validation of a clinical prediction score for targeted screening among people living with HIV in Ghana(2021)
Authors: Kwasi Torpey, Lily Ogyiri, Vicky Cuylaerts, Seth Agyeman, Adwoa Agyei-Nkansah, Jozefien Buyze, Joseph Oliver Commey, Lut Lynen, Anja De Weggheleire
- Miltefosine for the treatment of cutaneous leishmaniasis: a pilot study from Ethiopia(2021)
Authors: Saskia van Henten, Annisa Befekadu Tesfaye, Seid Getahun Abdela, Feleke Tilahun, Helina Fikre, Jozefien Buyze, Mekibib Kassa, Lieselotte Cnops, Myrthe Pareyn, Rezika Mohammed, et al.
- Recurrent sexually transmitted infections among a cohort of men who have sex with men using pre-exposure prophylaxis in Belgium are highly associated with sexualized drug use(2021)
Authors: Irith De Baetselier, Thijs Reyniers, Tom Platteau, Kristien Wouters, Christiana Nöstlinger, Vicky Cuylaerts, Jozefien Buyze, Marie Laga, Christopher Kenyon, T. Crucitti, et al.
Pages: 726-732 - Antibacterial mouthwash to prevent sexually transmitted infections in men who have sex with men taking HIV pre-exposure prophylaxis (PReGo): a randomised, placebo-controlled, crossover trial(2021)
Authors: Christophe Van Dijck, Achilleas Tsoumanis, Anke Rotsaert, Beatrijs Vuylsteke, Dorien Van den Bossche, Elke Paeleman, Irith De Baetselier, Isabel Brosius, Jolein Laumen, Jozefien Buyze, et al.
Pages: 657-667